Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Buy
123,118
+91,880
+294% +$20.4M 0.16% 136
2025
Q4
$5.06M Sell
31,238
-10,498
-25% -$1.82M 0.03% 375
2025
Q3
$6.3M Buy
41,736
+6,929
+20% +$924K 0.03% 333
2025
Q2
$4.47M Buy
34,807
+1,221
+4% +$119K 0.03% 373
2025
Q1
$2.42M Sell
33,586
-193,991
-85% -$20.6M 0.02% 457
2024
Q4
$25.9M Sell
227,577
-174,621
-43% -$20.7M 0.15% 140
2024
Q3
$40M Buy
402,198
+132,491
+49% +$11M 0.23% 98
2024
Q2
$23.3M Buy
269,707
+245,077
+995% +$22.3M 0.14% 149
2024
Q1
$2.01M Buy
24,630
+19,485
+379% +$1.22M 0.01% 509
2023
Q4
$247K Buy
+5,145
New +$219K ﹤0.01% 699

Other funds holding VRT

Candriam SCA's VRT Position: Q1 2026 in Review

Candriam SCA increased its Vertiv (VRT) stake by 294% in Q1 2026, buying an estimated $20.4M and bringing the position to 123,118 shares worth $30.9M. The position accounts for 0.16% of the portfolio, ranked #136.

Candriam SCA first reported a position in VRT in Q4 2023 and has held it in 10 quarters since. The position peaked at $40M in Q3 2024. 1,824 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • Candriam SCA held 123,118 shares of Vertiv worth $30.9M as of Q1 2026.
  • Candriam SCA bought 91,880 Vertiv shares in Q1 2026, an estimated $20.4M.
  • Vertiv made up 0.16% of Candriam SCA's portfolio in Q1 2026, its #136 holding.
  • Candriam SCA first reported a position in Vertiv in Q4 2023 and has held it in 10 quarters since.
  • Candriam SCA's Vertiv position peaked at $40M in Q3 2024.
  • 1,824 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.